{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:13:03Z","timestamp":1777464783156,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.yexcr.2013.12.007","type":"journal-article","created":{"date-parts":[[2013,12,16]],"date-time":"2013-12-16T06:45:38Z","timestamp":1387176338000},"page":"217-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["BH3-mimetic drugs prevent tumour onset in an orthotopic mouse model of hepatoblastoma"],"prefix":"10.1016","volume":"322","author":[{"given":"Justus","family":"Lieber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena","family":"Ellerkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Wenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven W.","family":"Warmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorin","family":"Armeanu-Ebinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.yexcr.2013.12.007_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejca.2003.06.003","article-title":"Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology\u2014SIOPEL 2","volume":"40","author":"Perilongo","year":"2004","journal-title":"Eur. J. Cancer"},{"issue":"9","key":"10.1016\/j.yexcr.2013.12.007_bib2","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1517\/14712590903136696","article-title":"Emerging gene-directed anti-tumor strategies against human hepatoblastoma","volume":"9","author":"Warmann","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"issue":"6","key":"10.1016\/j.yexcr.2013.12.007_bib3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.humpath.2008.10.022","article-title":"Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways","volume":"40","author":"Adesina","year":"2009","journal-title":"Hum. Pathol."},{"issue":"6","key":"10.1016\/j.yexcr.2013.12.007_bib4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/pbc.22740","article-title":"Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells","volume":"55","author":"Lieber","year":"2010","journal-title":"Pediatr. Blood Cancer"},{"issue":"4","key":"10.1016\/j.yexcr.2013.12.007_bib5","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1158\/1078-0432.CCR-08-0144","article-title":"Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy","volume":"15","author":"Kang","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"Suppl 1","key":"10.1016\/j.yexcr.2013.12.007_bib6","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1038\/onc.2009.52","article-title":"Mimicking the BH3 domain to kill cancer cells","volume":"27","author":"Chonghaile","year":"2008","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.yexcr.2013.12.007_bib7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/1471-2407-11-362","article-title":"The BH3 mimetic ABT-737 increases treatment efficiency of paclitaxel against hepatoblastoma","volume":"11","author":"Lieber","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexcr.2013.12.007_bib8","article-title":"Apoptosis sensitizers enhance cytotoxicity in hepatoblastoma cells","author":"Lieber","year":"2011","journal-title":"Pediatr. Surg. Int."},{"issue":"7042","key":"10.1016\/j.yexcr.2013.12.007_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours","volume":"435","author":"Oltersdorf","year":"2005","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.yexcr.2013.12.007_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.biocel.2009.11.015","article-title":"Cellular FLICE-inhibitory protein (c-FLIP) signalling: a key regulator of receptor-mediated apoptosis in physiologic context and in cancer","volume":"42","author":"Bagnoli","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.yexcr.2013.12.007_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/156800908783497087","article-title":"WU C H. Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy","volume":"8","author":"Safa","year":"2008","journal-title":"Curr. Cancer Drug Targets"},{"issue":"4","key":"10.1016\/j.yexcr.2013.12.007_bib12","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.2741\/e536","article-title":"Proteasome inhibition overcomes TRAIL resistance in human hepatoblastoma cells","volume":"1","author":"Armeanu-Ebinger","year":"2012","journal-title":"Front. Biosci."},{"issue":"6","key":"10.1016\/j.yexcr.2013.12.007_bib13","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/jcb.22359","article-title":"RNAi-mediated silencing of insulin receptor substrate-4 enhances actinomycin D- and tumor necrosis factor-alpha-induced cell death in hepatocarcinoma cancer cell lines","volume":"108","author":"Cuevas","year":"2009","journal-title":"J. Cell Biochem."},{"issue":"1","key":"10.1016\/j.yexcr.2013.12.007_bib14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/jcb.240560110","article-title":"Rationale for using TNF alpha and chemotherapy in regional therapy of melanoma","volume":"56","author":"Lejeune","year":"1994","journal-title":"J. Cell Biochem."},{"issue":"6A","key":"10.1016\/j.yexcr.2013.12.007_bib15","first-page":"4087","article-title":"A new method of antitumor therapy with a high dose of TNF perfusion for unresectable liver tumors","volume":"20","author":"Nakamoto","year":"2000","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.yexcr.2013.12.007_bib16","first-page":"809","article-title":"D. Characterization of the continuous cell line HepT1 derived from a human hepatoblastoma","volume":"74","author":"Pietsch","year":"1996","journal-title":"Lab. Invest."},{"key":"10.1016\/j.yexcr.2013.12.007_bib17","unstructured":"DOI I. Establishment of a Cell Line and its Clonal Sublines from a Patient with Hepatoblastoma. Gann, 67(1), 1976 pp. 1\u201310."},{"issue":"8","key":"10.1016\/j.yexcr.2013.12.007_bib18","doi-asserted-by":"crossref","first-page":"e23419","DOI":"10.1371\/journal.pone.0023419","article-title":"Successful establishment of an orthotopic hepatoblastoma in vivo model in NOD\/LtSz-scid IL2Rgammanull mice","volume":"6","author":"Ellerkamp","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.yexcr.2013.12.007_bib19","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1158\/0008-5472.CAN-09-3535","article-title":"A Bax-mediated mechanism for obatoclax-induced apoptosis of cholangiocarcinoma cells","volume":"70","author":"Smoot","year":"2010","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.yexcr.2013.12.007_bib20","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","article-title":"Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells","volume":"174","author":"Shultz","year":"2005","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.yexcr.2013.12.007_bib21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1124\/mol.109.060780","article-title":"The Bcl-2 homology domain 3 mimetic ABT-737 targets the apoptotic machinery in acute lymphoblastic leukemia resulting in synergistic in vitro and in vivo interactions with established drugs","volume":"77","author":"High","year":"2010","journal-title":"Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.yexcr.2013.12.007_bib22","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1158\/0008-5472.CAN-07-1919","article-title":"Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax)","volume":"68","author":"Konopleva","year":"2008","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.yexcr.2013.12.007_bib23","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/cdd.2009.48","article-title":"Different forms of cell death induced by putative BCL2 inhibitors","volume":"16","author":"Vogler","year":"2009","journal-title":"Cell Death Differ."},{"issue":"8","key":"10.1016\/j.yexcr.2013.12.007_bib24","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.cdd.4401937","article-title":"Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins","volume":"13","author":"zhai","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yexcr.2013.12.007_bib25","doi-asserted-by":"crossref","DOI":"10.3892\/or.2012.2150","article-title":"Increased efficacy of CDDP in a xenograft model of hepatoblastoma using the apoptosis sensitizer ABT-737","author":"Lieber","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.yexcr.2013.12.007_bib26","first-page":"6","article-title":"Efficiency of recombinant human TNF in human cancer therapy","volume":"6","author":"Lejeune","year":"2006","journal-title":"Cancer Immunol."},{"issue":"7","key":"10.1016\/j.yexcr.2013.12.007_bib27","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s11095-009-9895-1","article-title":"Programmed cell death pathways and current antitumor targets","volume":"26","author":"Tan","year":"2009","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.yexcr.2013.12.007_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/hep.21054","article-title":"HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL","volume":"43","author":"Pathil","year":"2006","journal-title":"Hepatology"},{"issue":"14","key":"10.1016\/j.yexcr.2013.12.007_bib29","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1158\/0008-5472.CAN-04-4252","article-title":"Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate","volume":"65","author":"Armeanu","year":"2005","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.yexcr.2013.12.007_bib30","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/sj.cdd.4402081","article-title":"Bcl-2 family proteins are essential for platelet survival","volume":"14","author":"Zhang","year":"2007","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.yexcr.2013.12.007_bib31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jhep.2006.03.018","article-title":"Subcutaneous and intrahepatic growth of human hepatoblastoma in immunodeficient mice","volume":"45","author":"Schnater","year":"2006","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.yexcr.2013.12.007_bib32","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/ijc.20481","article-title":"Interactions between rat colon carcinoma cells and Kupffer cells during the onset of hepatic metastasis","volume":"112","author":"Timmers","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.yexcr.2013.12.007_bib33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2010.04.023","article-title":"Experimentally induced liver metastases from colorectal cancer can be prevented by mononuclear phagocyte-mediated monoclonal antibody therapy","volume":"53","author":"Van Der Bij","year":"2010","journal-title":"J. Hepatol."},{"issue":"1\u20132","key":"10.1016\/j.yexcr.2013.12.007_bib34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.canlet.2005.12.040","article-title":"Soluble TRAIL gene and actinomycin D synergistically suppressed multiple metastasis of TRAIL-resistant colon cancer in the liver","volume":"245","author":"Ishii","year":"2007","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.yexcr.2013.12.007_bib35","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/hep.510230542","article-title":"Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver","volume":"23","author":"Bayon","year":"1996","journal-title":"Hepatology"},{"issue":"15","key":"10.1016\/j.yexcr.2013.12.007_bib36","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1158\/1078-0432.CCR-10-0822","article-title":"Phase I dose finding studies of obatoclax (GX15-070), a small molecule pan-BCL-2 family antagonist, in patients with advanced solid tumors or lymphoma","volume":"16","author":"Hwang","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.yexcr.2013.12.007_bib37","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00280-010-1265-5","article-title":"A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies","volume":"66","author":"Paik","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"24","key":"10.1016\/j.yexcr.2013.12.007_bib38","doi-asserted-by":"crossref","first-page":"8295","DOI":"10.1158\/1078-0432.CCR-08-0999","article-title":"A phase I study of the pan bcl-2 family inhibitor obatoclax mesylate in patients with advanced hematologic malignancies","volume":"14","author":"Schimmer","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.yexcr.2013.12.007_bib39","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1182\/blood-2006-10-047951","article-title":"Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma","volume":"109","author":"Trudel","year":"2007","journal-title":"Blood"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482713005247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482713005247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T23:28:49Z","timestamp":1564961329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482713005247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0014482713005247"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2013.12.007","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BH3-mimetic drugs prevent tumour onset in an orthotopic mouse model of hepatoblastoma","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2013.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}